Bernard Padovani

Nice, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Correction: The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate.

Correction: The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate.

Journal: Trials

Published: April 02, 2025

The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate.

The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate.

Journal: Trials

Published: August 01, 2024

Integrating artificial intelligence into lung cancer screening: a randomised controlled trial protocol.

Integrating artificial intelligence into lung cancer screening: a randomised controlled trial protocol.

Journal: BMJ open

Published: February 14, 2024

Exercise-induced myocardial T1 increase and right ventricular dysfunction in recreational cyclists: a CMR study.

Exercise-induced myocardial T1 increase and right ventricular dysfunction in recreational cyclists: a CMR study.

Journal: European journal of applied physiology

Published: February 13, 2023

Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.

Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.

Journal: Radiation oncology (London, England)

Published: July 31, 2022

Exuberant cystic destruction of lung parenchyma.

Exuberant cystic destruction of lung parenchyma.

Journal: Respiratory medicine and research

Published: January 13, 2020

Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab.

Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab.

Journal: Bulletin du cancer

Published: December 24, 2019

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.

Journal: The Lancet. Respiratory medicine

Published: December 05, 2019

CT-guided percutaneous biopsies of mediastinal and paramediastinal masses in the lateral decubitus position.

CT-guided percutaneous biopsies of mediastinal and paramediastinal masses in the lateral decubitus position.

Journal: European radiology

Published: September 26, 2019

A case report of exogenous lipoid pneumonia associated with avocado/soybean unsaponifiables.

A case report of exogenous lipoid pneumonia associated with avocado/soybean unsaponifiables.

Journal: BMC pulmonary medicine

Published: March 26, 2019

Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer.

Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer.

Journal: BMC cancer

Published: February 18, 2019

Multi-modality imaging in repaired anomalous left coronary artery arising from the pulmonary artery.

Multi-modality imaging in repaired anomalous left coronary artery arising from the pulmonary artery.

Journal: European heart journal. Cardiovascular Imaging

Published: February 26, 2018

Showing 1-12 of 32

Last Updated: 09/26/2026